Ptosis

A 15-year-old high school student presented to the pediatric ophthalmology clinic for ptosis.

As an eye care provider, I know it can be frustrating to identify an ocular abnormality without a readily available treatment.

A 68-year-old woman presented to the Lahey Clinic emergency room with worsening pain, swelling and redness in her right eye.

Fatty infiltration of the levator muscle has been studied widely as a contributing factor in the pathogenesis of congenital, acquired and involutional ptosis.

The buzz on social media around Upneeq motivated me to investigate this nonsurgical, pharmaceutical approach to blepharoptosis.

A 37-year-old Native American man presented at the hospital complaining of painful left eye with vision loss and a drooping eyelid for the past 2 days.

In July 2020, the FDA approved Upneeq for acquired blepharoptosis in adults. After having participated in the clinical trials, I am now finding it has significant clinical utility in my everyday practice — see my previous blog on Upneeq.

With almost every exam these days, it seems like patients hate the dreaded phrase “due to your age.” I usually lighten up the verbiage and refer to it as the “A-G-E syndrome” that all of us encounter daily.

A few years back, our clinical research department was approached by Icon, a clinical research organization running what sounded like an interesting study.

Intraoperative antibiotic use during frontalis suspension surgery with a silicone rod sling decreased the risk of sling exposure or infection, according to a study.